Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

3 results

Filters applied: . Clear all
Page 1
Tenofovir disoproxil fumarate treatment in HbeAg-positive patients.
Ayaz C, Çelen MK, Dal T, Deveci Ö, Bayan K, Mert D, Oruç E, Özcan N, Kandemir I, Dal MS. Ayaz C, et al. Among authors: bayan k. Infez Med. 2015 Mar;23(1):31-5. Infez Med. 2015. PMID: 25819048 Free article.
Tenofovir disoproxil fumarate (Tenofovir DF) is a nucleotide analogue. This multicentre study reports retrospectively the long-term efficacy and safety data with tenofovir DF treatment in nucleosid(t)e-naive, hepatitis B e antigen (HBeAg)-positive chronic hepatitis B patie …
Tenofovir disoproxil fumarate (Tenofovir DF) is a nucleotide analogue. This multicentre study reports retrospectively the long-term e …
Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura.
Altintas A, Pasa S, Cil T, Bayan K, Gokalp D, Ayyildiz O. Altintas A, et al. Among authors: bayan k. Platelets. 2008 Jun;19(4):252-7. doi: 10.1080/09537100801894651. Platelets. 2008. PMID: 18569860
None of the CD related auto antibody positive patients developed clinically manifested CD. Large-scale designed studies are needed to clarify the long-term impact and importance of these CD related auto antibodies in patients with cITP....
None of the CD related auto antibody positive patients developed clinically manifested CD. Large-scale designed studies are needed to clarif …
Long-term conventional interferon alpha in combination with lamivudine for chronic hepatitis B: data from Turkey.
Yilmaz S, Bayan K, Dursun M, Canoruç F, Paşa S, Saka G. Yilmaz S, et al. Among authors: bayan k. Hepatogastroenterology. 2007 Dec;54(80):2348-52. Hepatogastroenterology. 2007. PMID: 18265662 Clinical Trial.
The aim of this study was to evaluate the efficacy and safety of the long-term interferon-alpha plus lamivudine on these patients, and thereafter the co-effect of maintenance therapy by lamivudine. ...Decompensation or hepatocellular carcinoma did not observe in any case. …
The aim of this study was to evaluate the efficacy and safety of the long-term interferon-alpha plus lamivudine on these patients, an …